Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease

BackgroundAssessment of risk and early diagnosis of Alzheimer's disease (AD) is a key to its prevention or slowing the progression of the disease. Previous research on risk factors for AD typically utilizes statistical comparison tests or stepwise selection with regression models. Outcomes of these methods tend to emphasize single risk factors rather than a combination of risk factors. However, a combination of factors, rather than any one alone, is likely to affect disease development. Genetic algorithms (GA) can be useful and efficient for searching a combination of variables for the best achievement (eg. accuracy of diagnosis), especially when the search space is large, complex or poorly understood, as in the case in prediction of AD development.ResultsMultiple sets of neuropsychological tests were identified by GA to best predict conversions between clinical categories, with a cross validated AUC (area under the ROC curve) of 0.90 for prediction of HC conversion to MCI/AD and 0.86 for MCI conversion to AD within 36 months.ConclusionsThis study showed the potential of GA application in the neural science area. It demonstrated that the combination of a small set of variables is superior in performance than the use of all the single significant variables in the model for prediction of progression of disease. Variables more frequently selected by GA might be more important as part of the algorithm for prediction of disease development.

[1]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[2]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[3]  Lucila Ohno-Machado,et al.  A genetic algorithm to select variables in logistic regression: example in the domain of myocardial infarction , 1999, AMIA.

[4]  C. Rowe,et al.  Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing , 2013, Annals of neurology.

[5]  Dorothea Heiss-Czedik,et al.  An Introduction to Genetic Algorithms. , 1997, Artificial Life.

[6]  Robert D. Latzman,et al.  The Factor Structure and Age-Related Factorial Invariance of the Delis-Kaplan Executive Function System (D-KEFS) , 2010, Assessment.

[7]  Jewel Swanson.  The Delis-Kaplan Executive Function System , 2005 .

[8]  P. S. Achilles.  THE PSYCHOLOGICAL CORPORATION. , 1923, Science.

[9]  C. Jack,et al.  Mild cognitive impairment due to Alzheimer disease in the community , 2013, Annals of neurology.

[10]  K. Yaffe,et al.  The projected effect of risk factor reduction on Alzheimer's disease prevalence , 2011, The Lancet Neurology.

[11]  Paul Maruff,et al.  Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) , 2013, International Psychogeriatrics.

[12]  Melanie Mitchell,et al.  An introduction to genetic algorithms , 1996 .

[13]  M. Jorge Cardoso,et al.  Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment☆ , 2013, NeuroImage: Clinical.

[14]  G Ratcliff,et al.  Normative Data on the Boston Naming Test and Two Equivalent 30-Item Short Forms , 2000, The Clinical neuropsychologist.

[15]  Suzanne B Hendrix,et al.  Separation of cognitive domains to improve prediction of progression from mild cognitive impairment to Alzheimer's disease , 2013, Alzheimer's Research & Therapy.

[16]  The MENTAL health research institute. , 1960, Medical bulletin.

[17]  O. Spreen,et al.  Comprar A Compendium of Neuropsychological Tests - Administration, Norms, and Commentary | Esther Strauss | 9780195159578 | Oxford University Press , 2009 .

[18]  E G Tangalos,et al.  The incidence of MCI differs by subtype and is higher in men , 2012, Neurology.

[19]  Paul Maruff,et al.  Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease. , 2013, Neuropsychology.

[20]  Simon Günter,et al.  Stratification bias in low signal microarray studies , 2007, BMC Bioinformatics.

[21]  P. Trzepacz,et al.  Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia , 2013, Neurobiology of Aging.

[22]  C. Rowe,et al.  The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease , 2009, International Psychogeriatrics.

[23]  E B Larson,et al.  Alzheimer's disease in the community. , 1989, JAMA.

[24]  Vladimir Fonov,et al.  Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning , 2013, NeuroImage.

[25]  O. Spreen,et al.  A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary , 1991 .

[26]  J. Duchek,et al.  Reliability of the Washington University Clinical Dementia Rating. , 1988, Archives of neurology.

[27]  L. Marks,et al.  A genetic algorithm for variable selection in logistic regression analysis of radiotherapy treatment outcomes. , 2008, Medical physics.

[28]  C. Metz.  ROC Methodology in Radiologic Imaging , 1986, Investigative radiology.

[29]  Lakhmi C. Jain,et al.  Neural Network Training Using Genetic Algorithms , 1996 .

[30]  Jas. Middlemass,et al.  Archives of Neurology , 1903, British medical journal.

[31]  D. Wechsler.  A Standardized Memory Scale for Clinical Use , 1945 .

[32]  H. Akaike.  A new look at the statistical model identification , 1974 .

[33]  T. Goldberg,et al.  Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. , 2011, Archives of general psychiatry.

[34]  H. Levin.  A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary , 1993 .

[35]  M. Freedman,et al.  Clock Drawing: A Neuropsychological Analysis , 1994 .

[36]  Mark E. Schmidt,et al.  The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.

[37]  Paul Maruff,et al.  The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI , 2013, International Psychogeriatrics.

[38]  R. Dean,et al.  TEST REVIEW: Dean C. Delis, Edith Kaplan & Joel H. Kramer, Delis Kaplan Executive Function System (D-KEFS), The Psychological Corporation, San Antonio, TX, 2001. $415.00 (complete kit) , 2006 .

[39]  Dharmender Kumar,et al.  A Comparative Analysis of Selection Schemes in the Artificial Bee Colony Algorithm , 2016, Computación y Sistemas.

[40]  B. Reisberg,et al.  Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease , 2008, International Psychogeriatrics.

[41]  J A Swets,et al.  Measuring the accuracy of diagnostic systems. , 1988, Science.

[42]  Paul Maruff,et al.  Predictors of cognitive decline at 18 month follow up among 1112 participants in the Australian imaging, biomarkers and lifestyle flagship study of ageing (AIBL) , 2011, Alzheimer's & Dementia.